|
R43NS070483
|
Department of Health and Human Services
|
93.853 - EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS
|
2011-01-15
|
2011-07-20
|
TRIPLEX-INDUCED CORRECTION OF IDUA MUTATIONS AS A NOVEL HURLER SYNDROME THERAPY
|
|
| Recipient |
HELIX THERAPEUTICS, LLC
|
| Recipient Name Raw |
HELIX THERAPEUTICS LLC
|
| Recipient UEI |
Z4YSQTYVCUF5
|
| Recipient DUNS |
788852437
|
| Recipient Address |
29 NORTH POND ROAD, CHESHIRE, NEW HAVEN, CONNECTICUT, 06410-1249, UNITED STATES
|
| Obligated Amount |
0.00
|
| Non-Federal Funding |
0.00
|
| Original Subsidy Cost |
0.00
|
| Face Value of Direct Loan |
0.00
|
| Link |
View Page
|
|
|
R43HL099058
|
Department of Health and Human Services
|
93.839 - BLOOD DISEASES AND RESOURCES RESEARCH
|
2010-08-01
|
2011-07-31
|
BETA-GLOBIN GENE CORRECTION USING PEPTIDE NUCLEIC ACIDS FOR THE TREATMENT OF SICK
|
|
| Recipient |
HELIX THERAPEUTICS, LLC
|
| Recipient Name Raw |
HELIX THERAPEUTICS LLC
|
| Recipient UEI |
Z4YSQTYVCUF5
|
| Recipient DUNS |
788852437
|
| Recipient Address |
29 NORTH POND ROAD, CHESHIRE, NEW HAVEN, CONNECTICUT, 06410-1249, UNITED STATES
|
| Obligated Amount |
228490.00
|
| Non-Federal Funding |
0.00
|
| Original Subsidy Cost |
0.00
|
| Face Value of Direct Loan |
0.00
|
| Link |
View Page
|
|
|
R43AI076193
|
Department of Health and Human Services
|
93.855 - ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH
|
2008-05-01
|
2008-10-31
|
TARGETED CCR5 GENE INACTIVATION USING PEPTIDE NUCLEIC ACIDS
|
|
| Recipient |
HELIX THERAPEUTICS, LLC
|
| Recipient Name Raw |
HELIX THERAPEUTICS LLC
|
| Recipient UEI |
Z4YSQTYVCUF5
|
| Recipient DUNS |
788852437
|
| Recipient Address |
29 NORTH POND ROAD, CHESHIRE, NEW HAVEN, CONNECTICUT, 06410
|
| Obligated Amount |
99999.00
|
| Non-Federal Funding |
0.00
|
| Original Subsidy Cost |
0.00
|
| Face Value of Direct Loan |
0.00
|
| Link |
View Page
|
|
